Procedure
Nasal lavage
Nasal lavage is a medical procedure with 8 clinical trials. Historical success rate of 85.7%.
Total Trials
8
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
85.7%
Based on 6 completed trials
Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)
Phase Distribution
Ph phase_1
2
25%
Ph phase_2
1
13%
Ph not_applicable
4
50%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
4(57.1%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
85.7%
6 of 7 finished
Non-Completion Rate
14.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
8
all time
Status Distribution
Completed(6)
Terminated(1)
Other(1)
Detailed Status
Completed6
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (28.6%)
Phase 21 (14.3%)
N/A4 (57.1%)
Trials by Status
terminated113%
completed675%
unknown113%
Recent Activity
0 active trials
Showing 5 of 8
completedphase_1
Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00159341
completedphase_2
Repeat Nasal Allergen Challenge
NCT00290368
unknown
Asthma: Phenotyping Exacerbations 3
NCT05446090
completednot_applicable
Nasal Irrigation to Reduce COVID-19 Morbidity
NCT04559035
completedphase_1
The Anti-allergic Effects of Specific Probiotics
NCT00480129
Clinical Trials (8)
Showing 8 of 8 trials
NCT00159341Phase 1
Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00290368Phase 2
Repeat Nasal Allergen Challenge
NCT05446090
Asthma: Phenotyping Exacerbations 3
NCT04559035Not Applicable
Nasal Irrigation to Reduce COVID-19 Morbidity
NCT00480129Phase 1
The Anti-allergic Effects of Specific Probiotics
NCT03039101Not Applicable
Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
NCT01847768Not Applicable
Human Rhinovirus Infection and Airway Remodeling Mediators
NCT00229190Not Applicable
Nasal Lavage Study: Comparing Single Versus Multi Sample Lavages
All 8 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 8